142 related articles for article (PubMed ID: 2729933)
1. Comparative in vitro antimicrobial susceptibilities of a special panel of 74 Bacteroides fragilis group isolates in Wilkins-Chalgren agar with and without sheep blood.
Gill CJ; Shungu DL; Ponticas S
Antimicrob Agents Chemother; 1989 Mar; 33(3):394-5. PubMed ID: 2729933
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of 114 isolates of the Bacteroides fragilis group to imipenem and eight other antimicrobial agents.
Downes J; Andrew JH
Pathology; 1988 Jul; 20(3):260-3. PubMed ID: 3205597
[TBL] [Abstract][Full Text] [Related]
3. Effect of inoculum size and medium on activity of seven antimicrobial agents against Bacteroides fragilis strains.
Wexler HM; Reeves D; Finegold SM
Clin Ther; 1989; 11(6):828-33. PubMed ID: 2611824
[TBL] [Abstract][Full Text] [Related]
4. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
Goldstein EJ; Citron DM; Cherubin CE; Hillier SL
J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of agar dilution and broth microdilution by commercial and in-house plates for Bacteroides fragilis group: An economical and expeditious approach for resource-limited settings.
Sood A; Angrup A; Ray P; Bala K
Anaerobe; 2021 Oct; 71():102443. PubMed ID: 34492368
[TBL] [Abstract][Full Text] [Related]
6. Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates.
Nagy E; Justesen US; Eitel Z; Urbán E;
Anaerobe; 2015 Feb; 31():65-71. PubMed ID: 25464140
[TBL] [Abstract][Full Text] [Related]
7. Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989.
Betriu C; Cabronero C; Gomez M; Picazo JJ
Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):352-6. PubMed ID: 1396757
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibilities of the Bacteroides fragilis group to 14 antimicrobial agents in Korea.
Lee K; Jang IH; Kim YJ; Chong Y
Antimicrob Agents Chemother; 1992 Jan; 36(1):195-7. PubMed ID: 1590688
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal study of susceptibilities of species of the Bacteroides fragilis group to five antimicrobial agents in three medical centers.
Turgeon P; Turgeon V; Gourdeau M; Dubois J; Lamothe F
Antimicrob Agents Chemother; 1994 Oct; 38(10):2276-9. PubMed ID: 7840557
[TBL] [Abstract][Full Text] [Related]
10. Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.
Appelbaum PC; Spangler SK; Jacobs MR
Antimicrob Agents Chemother; 1990 Aug; 34(8):1546-50. PubMed ID: 2221864
[TBL] [Abstract][Full Text] [Related]
11. Resistance trends of Bacteroides fragilis group over an 8-year period, 1997-2004, in Korea.
Roh KH; Kim S; Kim CK; Yum JH; Kim MS; Yong D; Lee K; Kim JM; Chong Y
Korean J Lab Med; 2009 Aug; 29(4):293-8. PubMed ID: 19726890
[TBL] [Abstract][Full Text] [Related]
12. Resistance profile of Bacteroides fragilis isolated in Brazil. Do they shelter the cfiA gene?
das Graças Silva E Souza W; Avelar KE; Antunes LC; Lobo LA; Domingues RM; de Souza Ferreira MC
J Antimicrob Chemother; 2000 Apr; 45(4):475-81. PubMed ID: 10747824
[TBL] [Abstract][Full Text] [Related]
13. [Activity of seven antimicrobial agents against "Bacteroides fragilis" (author's transl)].
Tytgat F
Ann Microbiol (Paris); 1980; 131(1):39-44. PubMed ID: 6899739
[TBL] [Abstract][Full Text] [Related]
14. Effect of inoculum, pH, and medium on the activity of ciprofloxacin against anaerobic bacteria.
Borobio MV; Perea EJ
Antimicrob Agents Chemother; 1984 Mar; 25(3):342-3. PubMed ID: 6721466
[TBL] [Abstract][Full Text] [Related]
15. Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents.
Betriu C; Campos E; Cabronero C; Rodriguez-Avial C; Picazo JJ
Antimicrob Agents Chemother; 1990 Apr; 34(4):671-3. PubMed ID: 2344174
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility patterns and resistance to imipenem in the Bacteroides fragilis group species in Japan: a 4-year study.
Bandoh K; Ueno K; Watanabe K; Kato N
Clin Infect Dis; 1993 Jun; 16 Suppl 4():S382-6. PubMed ID: 8324152
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H
Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852
[TBL] [Abstract][Full Text] [Related]
18. [Comparative effect of apalcillin and other beta-lactam antibiotics against the Bacteroides fragilis group].
Dusart G; Simeon de Buochberg M; Zuccarelli M; Attisso MA; Willemin C
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):523-7. PubMed ID: 2797878
[TBL] [Abstract][Full Text] [Related]
19. Survey of antimicrobial susceptibility patterns of the bacteria of the Bacteroides fragilis group isolated from the intestinal tract of children.
Nakano V; Avila-Campos MJ
Mem Inst Oswaldo Cruz; 2004 May; 99(3):319-24. PubMed ID: 15273807
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of clinical isolates of Bacteroides fragilis and Bacteroides thetaiotaomicron in Japan.
Watanabe K; Ueno K; Kato N; Muto Y; Bandoh K; Tanaka Y; Jotwani R; Goto M; Shimada K; Shimizu K
Eur J Clin Microbiol Infect Dis; 1992 Nov; 11(11):1069-73. PubMed ID: 1295761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
